Skip to content

Comparison of Visual Outcomes After Implantation of the Synthesis Plus and Synthesis Plus Toric

Comparison of Visual Outcomes After Implantation of the Synthesis Plus and Synthesis Plus Toric

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05561478
Acronym
DETPLUST
Enrollment
72
Registered
2022-09-30
Start date
2022-10-10
Completion date
2025-10-31
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, IOL, Surgery

Brief summary

Prospective controlled monocentric study to determine the non-inferiority of the distance-corrected intermediate visual acuity at 66 cm of the SYNTHESIS PLUS TORIC with respect to the SYNTHESIS PLUS IOL.

Interventions

DEVICEImplantation of Synthesis Plus IOL (control device)

Synthesis Plus IOLs are indicated for primary implantation for the visual correction of aphakia in adult patients.

DEVICEImplantation of Synthesis Plus Toric IOL (investigational device)

Synthesis Plus Toric IOLs are indicated for primary implantation for the visual correction of aphakia in adult patients with pre-existing astigmatism.

Sponsors

Cutting Edge SAS
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient older than 50 years old * Patient requiring bilateral cataract surgery * Regular corneal astigmatism \>0.5D measured by MS-39 (SimK keratometry and regularity determined by the topography) for patients implanted with SYNTHESIS PLUS TORIC or Regular corneal astigmatism lower or equal to 0.5 D dioptres by MS-39 (SimK keratometry and regularity determined by the topography) for patients implanted with SYNTHESIS PLUS. * Expected postoperative astigmatism ≤ 0.75D diopter * Corneal astigmatism ≤4D * IOL spherical equivalent power requested between 15D and 25D * Signed informed consent * Availability, willingness and sufficient cognitive awareness to comply with examination procedures Non inclusion Criteria: * Patients with a potential postoperative visual acuity of less than 5/10, in particular due to degenerative visual disorders, poor retinal function or a damaged cornea. * Amblyopia with a visual acuity potential of less than 5/10 * IOL power needed outside the spherical equivalent diopter range: 15 to 25D * Difficulty for cooperation (distance from their home, general health condition) * Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…) * Irregular astigmatism * Subject with postoperative astigmatism, expected \> 0.75 D. * Any ocular comorbidity * History of ocular trauma or prior ocular surgery including refractive procedures * Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome) * Patients with chronic uveitis * Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions, diameter (pupil\>4mm or \<2.5 mm in photopic conditions)) * Narrow anterior chambers (ACD ≤ 2.5 mm) * Any corneal pathology potentially affecting the topography (eg. Keratoconus), * Monophthalma patients * Phacodonesis

Exclusion criteria

* Complicated surgery * Inability to place the intraocular lens safely at the location planned * Subjects with zonular laxity * Postoperative endophthalmitis

Design outcomes

Primary

MeasureTime frameDescription
DCIVA at 66 cm1 monthThe primary objective of this study is to determine the non-inferiority of the distance-corrected intermediate visual acuity at 66 cm of the SYNTHESIS PLUS TORIC with respect to the SYNTHESIS PLUS

Secondary

MeasureTime frameDescription
Monocular BCDVA1 monthdistance
Monocular UIVA1 month66 cm
Monocular DCIVA1 month66 cm
Monocular UDVA1 monthdistance
Potential complications1 monthpostoperative
Rotational stabilityPeroperatively, day 0, Month 1in degrees
Subjective quality of vision1 monthPROM
Refraction1 monthsubjective

Countries

France

Contacts

Primary ContactLine Bettinelli, OD
line.bettinelli@cutting-edge.fr0619530701

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026